Gilead Sciences
Patents, Design & Utilities
Last updated:
List of all Gilead Sciences patents 302 in total
| Status | Patent |
|---|---|
Application | Utility: COMPOSITIONS COMPRISING AN RNA POLYMERASE INHIBITOR AND CYCLODEXTRIN FOR TREATING VIRAL INFECTIONS Filling date: 26 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS Filling date: 26 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: THERAPEUTIC COMPOUNDS Filling date: 26 Sep 2025 Issue date: 25 Aug 2022 |
Grant | Design: Blister pack Filling date: 26 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Substituted pyrrolizine compounds and uses thereof Filling date: 26 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Methods and compounds for treating Paramyxoviridae virus infections Filling date: 26 Sep 2025 Issue date: 23 Aug 2022 |
Application | Utility: LONG-ACTING FORMULATIONS OF TENOFOVIR ALAFENAMIDE Filling date: 26 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: COT MODULATORS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 18 Aug 2022 |
Grant | Design: Blister pack Filling date: 26 Sep 2025 Issue date: 16 Aug 2022 |
Application | Utility: SOLID FORMS OF AN HIV CAPSID INHIBITOR Filling date: 26 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: Choline Salt Forms of an HIV Capsid Inhibitor Filling date: 26 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: METABOLITES OF BICTEGRAVIR Filling date: 26 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: FXR (NR1H4) MODULATING COMPOUNDS Filling date: 26 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: Imidazopyrimidine Derivatives Filling date: 26 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: COT MODULATORS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 28 Jul 2022 |
Grant | Utility: Solid forms of a toll-like receptor modulator Filling date: 26 Sep 2025 Issue date: 26 Jul 2022 |
Grant | Design: Pharmaceutical package Filling date: 26 Sep 2025 Issue date: 26 Jul 2022 |
Grant | Design: Pharmaceutical package Filling date: 26 Sep 2025 Issue date: 26 Jul 2022 |
Application | Utility: INHIBITORS OF PEPTIDYLARGININE DEIMINASES Filling date: 26 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN Filling date: 26 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: HIV VACCINES AND METHODS OF USING Filling date: 26 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: TOLL LIKE RECEPTOR MODULATOR COMPOUNDS Filling date: 26 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: COMBINATION OF A TLR7 MODULATING COMPOUND AND AN HIV VACCINE Filling date: 26 Sep 2025 Issue date: 14 Jul 2022 |
Grant | Utility: Methods for treating Arenaviridae and Coronaviridae virus infections Filling date: 26 Sep 2025 Issue date: 12 Jul 2022 |
Application | Utility: SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS Filling date: 26 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: FXR (NR1H4) MODULATING COMPOUNDS Filling date: 26 Sep 2025 Issue date: 30 Jun 2022 |
Grant | Design: Pharmaceutical package Filling date: 26 Sep 2025 Issue date: 21 Jun 2022 |
Application | Utility: REMDESIVIR TREATMENT METHODS Filling date: 26 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: GLP-1R MODULATING COMPOUNDS Filling date: 26 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: PROCESSES AND INTERMEDIATES FOR PREPARING MCL1 INHIBITORS Filling date: 26 Sep 2025 Issue date: 9 Jun 2022 |
Grant | Utility: Thienopyrimidine derivatives as ACC inhibitors and uses thereof Filling date: 26 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: HIV protease inhibitors Filling date: 26 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Methods for the preparation of ribosides Filling date: 26 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: Combination formulation of three antiviral compounds Filling date: 26 Sep 2025 Issue date: 24 May 2022 |
Application | Utility: COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN Filling date: 26 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: METHODS OF IDENTIFYING HIV PATIENTS SENSITIVE TO THERAPY WITH gp120 CD4 BINDING SITE-DIRECTED ANTIBODIES Filling date: 26 Sep 2025 Issue date: 12 May 2022 |
Grant | Utility: Cot modulators and methods of use thereof Filling date: 26 Sep 2025 Issue date: 10 May 2022 |
Grant | Utility: Processes and intermediates for preparing MCL1 inhibitors Filling date: 26 Sep 2025 Issue date: 10 May 2022 |
Application | Utility: PROCESSES FOR PREPARING ASK1 INHIBITORS Filling date: 26 Sep 2025 Issue date: 5 May 2022 |
Grant | Utility: HIV protease inhibitors Filling date: 26 Sep 2025 Issue date: 3 May 2022 |
Application | Utility: INTERLEUKIN-2-Fc FUSION PROTEINS AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: PRODRUGS OF PHOSPHONAMIDE NUCLEOTIDE ANALOGUES AND THEIR PHARMACEUTICAL USE Filling date: 26 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: QUINOLINE DERIVATIVES AS ALPHA4BETA7 INTEGRIN INHIBITORS Filling date: 26 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: METHODS FOR TREATING HEPATITIS B VIRUS INFECTIONS USING NS5A, NS5B OR NS3 INHIBITORS Filling date: 26 Sep 2025 Issue date: 21 Apr 2022 |
Grant | Utility: Quinazoline compounds Filling date: 26 Sep 2025 Issue date: 19 Apr 2022 |
Application | Utility: THIADIAZOLE IRAK4 INHIBITORS Filling date: 26 Sep 2025 Issue date: 31 Mar 2022 |
Grant | Utility: Processes for preparing toll-like receptor modulator compounds Filling date: 26 Sep 2025 Issue date: 29 Mar 2022 |
Application | Utility: ANTIBODIES THAT TARGET HIV GP120 AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 24 Mar 2022 |
Grant | Utility: Processes for preparing ACC inhibitors and solid forms thereof Filling date: 26 Sep 2025 Issue date: 22 Mar 2022 |
Application | Utility: COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS Filling date: 26 Sep 2025 Issue date: 17 Mar 2022 |
Showing 1 to 50 of 302 patents.